Global Epiglottitis Treatment Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Epiglottitis is an infectious diseases caused by an infection from Haemophilus influenza type b (Hib) bacteria. In this condition epiglottis, a thin cartilage structure at the root of the tongue that closes off the windpipe when food is swallowed. Most common symptom of epiglottis are sour throat, discomfort in breathing, fever, and drooling etc. The increasing incidences of epiglottitis and growing per capita healthcare spending are factors that are accelerating the global market demand. For instance, according to National Center for Biotechnology Information estimates - the incidence rate of acute epiglottitis in adults ranges from 0.97 to 3.1 per 100,000, and a mortality rate of 7.1%. Moreover, as per Statista - in 2019, the global per capita health spending was estimated at USD 1,129, and as per estimation this amount is projected to grow to USD 1515 by 2050. Also, growing healthcare infrastructure in emerging economies coupled with increasing prevalence of bacterial diseases are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, side effects associated with Epiglottitis Treatment drugs impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Epiglottitis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing prevalence of immune system related diseases and presence of leading pharmaceuticals companies in the region. Whereas, Asia pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing incidences of bacterial diseases and rising healthcare sector in the region, would create lucrative growth prospects for the global Epiglottitis Treatment Market across the Asia Pacific region.
Major market players included in this report are:
Abbott
Merck & Co., Inc.
AstraZeneca
Boehringer Ingelheim International GmbH
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline Plc.
Johnson & Johnson
Roche Holding AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Broad-Spectrum Antibiotics
Targeted Antibiotic
Steroid Medication
By Route of Administration:
Oral Epiglottitis Treatment
Parental Epiglottitis Treatment
By End User:
Hospitals Pharmacies
Retail Pharmacies
Drug Stores
Clinics
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Epiglottitis Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
- 1.2.1. Global Epiglottitis Treatment Market, by Region, 2020-2028 (USD Million)
- 1.2.2. Global Epiglottitis Treatment Market, by Drug Type, 2020-2028 (USD Million)
- 1.2.3. Global Epiglottitis Treatment Market, by Route of Administration, 2020-2028 (USD Million)
- 1.2.4. Global Epiglottitis Treatment Market, by End User, 2020-2028 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Epiglottitis Treatment Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Epiglottitis Treatment Market Dynamics
- 3.1. Epiglottitis Treatment Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing incidences of epiglottitis.
- 3.1.1.2. Growing per capita healthcare spending.
- 3.1.2. Market Challenges
- 3.1.2.1. Side effects associated with Epiglottitis Treatment drugs.
- 3.1.3. Market Opportunities
- 3.1.3.1. Growing healthcare infrastructure in emerging economies.
- 3.1.3.2. Increasing prevalence of bacterial diseases.
Chapter 4. Global Epiglottitis Treatment Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Epiglottitis Treatment Market, by Drug Type
- 6.1. Market Snapshot
- 6.2. Global Epiglottitis Treatment Market by Drug Type, Performance - Potential Analysis
- 6.3. Global Epiglottitis Treatment Market Estimates & Forecasts by Drug Type 2018-2028 (USD Million)
- 6.4. Epiglottitis Treatment Market, Sub Segment Analysis
- 6.4.1. Broad-Spectrum Antibiotics
- 6.4.2. Targeted Antibiotic
- 6.4.3. Steroid Medication
Chapter 7. Global Epiglottitis Treatment Market, by Route of Administration
- 7.1. Market Snapshot
- 7.2. Global Epiglottitis Treatment Market by Route of Administration, Performance - Potential Analysis
- 7.3. Global Epiglottitis Treatment Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Million)
- 7.4. Epiglottitis Treatment Market, Sub Segment Analysis
- 7.4.1. Oral Epiglottitis Treatment
- 7.4.2. Parental Epiglottitis Treatment
Chapter 8. Global Epiglottitis Treatment Market, by End User
- 8.1. Market Snapshot
- 8.2. Global Epiglottitis Treatment Market by End User, Performance - Potential Analysis
- 8.3. Global Epiglottitis Treatment Market Estimates & Forecasts by End User 2018-2028 (USD Million)
- 8.4. Epiglottitis Treatment Market, Sub Segment Analysis
- 8.4.1. Hospitals Pharmacies
- 8.4.2. Retail Pharmacies
- 8.4.3. Drug Stores
- 8.4.4. Clinics
- 8.4.5. Online Pharmacies
Chapter 9. Global Epiglottitis Treatment Market, Regional Analysis
- 9.1. Epiglottitis Treatment Market, Regional Market Snapshot
- 9.2. North America Epiglottitis Treatment Market
- 9.2.1. U.S. Epiglottitis Treatment Market
- 9.2.1.1. Drug Type estimates & forecasts, 2018-2028
- 9.2.1.2. Route of Administration estimates & forecasts, 2018-2028
- 9.2.1.3. End User estimates & forecasts, 2018-2028
- 9.2.2. Canada Epiglottitis Treatment Market
- 9.3. Europe Epiglottitis Treatment Market Snapshot
- 9.3.1. U.K. Epiglottitis Treatment Market
- 9.3.2. Germany Epiglottitis Treatment Market
- 9.3.3. France Epiglottitis Treatment Market
- 9.3.4. Spain Epiglottitis Treatment Market
- 9.3.5. Italy Epiglottitis Treatment Market
- 9.3.6. Rest of Europe Epiglottitis Treatment Market
- 9.4. Asia-Pacific Epiglottitis Treatment Market Snapshot
- 9.4.1. China Epiglottitis Treatment Market
- 9.4.2. India Epiglottitis Treatment Market
- 9.4.3. Japan Epiglottitis Treatment Market
- 9.4.4. Australia Epiglottitis Treatment Market
- 9.4.5. South Korea Epiglottitis Treatment Market
- 9.4.6. Rest of Asia Pacific Epiglottitis Treatment Market
- 9.5. Latin America Epiglottitis Treatment Market Snapshot
- 9.5.1. Brazil Epiglottitis Treatment Market
- 9.5.2. Mexico Epiglottitis Treatment Market
- 9.6. Rest of The World Epiglottitis Treatment Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. Abbott
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. Product Summary
- 10.2.1.5. Recent Developments
- 10.2.2. Merck & Co., Inc.
- 10.2.3. AstraZeneca
- 10.2.4. Boehringer Ingelheim International GmbH
- 10.2.5. Pfizer Inc.
- 10.2.6. Sanofi
- 10.2.7. Teva Pharmaceutical Industries Ltd.
- 10.2.8. GlaxoSmithKline Plc.
- 10.2.9. Johnson & Johnson
- 10.2.10. Roche Holding AG
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption